Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: A monoinstitutional study

Gynecologic Oncology

Volumn 137, Issue 1, 2015, Pages 112-118

  Takahashi, Ryoko ^a   Mabuchi, Seiji ^a   Kawano, Mahiru ^a   Sasano, Tomoyuki ^a   Matsumoto, Yuri ^a   Kuroda, Hiromasa ^a   Hisamatsu, Takeshi ^a   Kozasa, Katsumi ^a   Sawada, Kenjiro ^a   Hamasaki, Toshimitsu ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial cancer; Neutrophilia; Surgery; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; NEUTROPHILIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT FAILURE; BLOOD; ENDOMETRIAL NEOPLASMS; LEUKOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929939547     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.02.006     Document Type: Article

References (24)

1. International Agency for Research on Cancer. GLOBACAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Lyon, France: IARC Press; 2014([cited 2014 Oct] Available from: http://globocan.iarc.fr/).
2. Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, et al. Comparative performance of the 2009 International Federation Of Gynecology and Obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 2010;116: 1141-9.
3. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004;35:649-62.
4. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491-505.
5. Tejerizo-García A, Jiménez-López JS, Muñoz-González JL, Bartolomé-Sotillos S, Marqueta-Marqués L, López-González G, et al. Overall survival and diseasefree survival in endometrial cancer: prognostic factors in 276 patients. Onco Targets Ther 2013;9:1305-13.
6. Salvesen HB, Haldorsen IS, Trovik J. Markers for individualised therapy in endometrial carcinoma. Lancet Oncol 2012;13:e353-61.
7. Granger JM, Kontoyiannis DP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients; a retrospective, single-institution study. Cancer 2009;115:3919-23.
8. Mabuchi S, Matsumoto Y, KawanoM, Minami K, Seo Y, Sasano T, et al. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature. J Natl Cancer Inst 2014;106.
9. Worley JrMJ, Nitschmann CC, Shoni M, Vitonis AF, Rauh-Hain JA, Feltmate CM. The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol 2012;125:561-5.
10. Worley Jr MJ, Nitschmann CC, Shoni M, Rauh-Hain JA, Williams KA, Feltmate CM. Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma. Int J Gynecol Cancer 2013;23:312-7.
11. Njølstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol 2013;131:410-5.
12. Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, et al. Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol 2010; 15:531-42.
13. Egawa-Takata T, Ueda Y, Kuragaki C, Miyake T, Miyatake T, Fujita M, et al. Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy. Cancer Chemother Pharmacol 2011;68:1603-10.
14. Kim HS, Han KH, Chung HH, Kim JW, Park NH, Song YS, et al. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol 2010;36:691-8.
15. Tavares-Murta BM, Mendonça MA, Duarte NL, da Silva JA, Mutão TS, Garcia CB, et al. Systemic leukocyte alterations are associated with invasive uterine cervical cancer. Int J Gynecol Cancer 2010;20:1154-9.
16. Santoni M, Buti S, Conti A, Porta C, Procopio G, Sternberg CN, et al. Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy. Target Oncol Jan 6 2015 (Epub).
17. Muriel López C, Esteban E, Berros JP, Pardo P, Astudillo A, Izquierdo M, et al. Prognostic factors in patients with advanced renal cell carcinoma. Clin Genitourin Cancer 2012;10:262-70.
18. Mabuchi S, Matsumoto Y, Hamasaki T, Kawano M, Hisamatsu T, Mutch DG, et al. Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer. Int J Gynecol Cancer 2012;22:1545-51.
19. Ruka W, Rutkowski P, Kaminska J, Rysinska A, Steffen J. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Ann Oncol 2001;12:1423-32.
20. Suh DH, KimHS, Chung HH, KimJW, Park NH, Song YS, et al. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 2012;162:206-10.
21. Wang D, Yang JX, Cao DY, Wan XR, Feng FZ, Huang HF, et al. Preoperative neutrophil- lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther 2013;6:211-6.
22. Mabuchi S, Matsumoto Y, Morii E, Morishige K, Kimura T. The first 2 cases of granulocyte colony-stimulating factor producing adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2010;29:483-7.
23. Mabuchi S, Matsumoto Y, Isohashi F, Yoshioka Y, Ohashi H, Morii E, et al. Leukocytosis is an indicator of poor prognosis in patientswith cervical cancer. GynecolOncol 2011;122: 25-32.
24. Yamamoto K, Mabuchi S, Yamasaki M, Yoshimura M, Murata Y. Grave outcome of granulocyte colony-stimulating factor-producing endometrial cancer: a case report and literature review. J Obstet Gynaecol Res 2013;39:1107-10.